Autek China Inc
Autek China Inc provides medical equipment, supplies, and distribution services within the healthcare sector.
Business. Autek China Inc (300595.SZ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, including capital equipment and consumables. Headquartered in China, the company is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Analyst recommendations
6 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Autek China Inc (300595.SZ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, including capital equipment and consumables. Headquartered in China, the company is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Autek China Inc maintains a strong liquidity position with a current ratio of 5.77, indicating a robust ability to meet short-term obligations. The company's liquidity_fpt score suggests a medium liquidity risk, which is consistent with its operating cash flow of 730,078,200 CNY and free cash flow of 327,817,940 CNY. However, the company has a net cash position that is negative after subtracting total debt, which may pose a liquidity risk in the medium term.
In terms of profitability, Autek China Inc demonstrates a return on equity (ROE) of 9.76% and a return on assets (ROA) of 7.66%, both of which are above the industry median for medical equipment and supplies firms. The company's operating income of 649,222,350 CNY and net income of 479,524,590 CNY reflect a healthy margin structure, supported by a gross profit of 1,343,291,200 CNY.
The company's geographic and segment exposure is not explicitly detailed in the available data, but its revenue concentration is likely within the domestic Chinese market, given its listing on the Shenzhen Stock Exchange and the absence of international revenue breakdowns. This may limit its exposure to global healthcare trends and diversify its risk profile.
Autek China Inc's growth trajectory is not explicitly outlined in the available data, but its revenue of 1,861,147,150 CNY and consistent operating cash flow suggest a stable business model. Analysts have assigned a mean price target of 16.28 CNY and a median price target of 17.75 CNY, with a mean recommendation of 2.83, indicating a generally positive outlook.
The company's risk profile is characterized by a low dilution risk, with no significant dilution sources identified in the available data. However, the negative net cash position after subtracting total debt may indicate a need for capital management or refinancing in the near term. The company's debt-to-equity ratio of 0.06 suggests a conservative capital structure, with long-term debt of 300,961,220 CNY and total equity of 4,911,934,620 CNY.
Recent events and filings have not been explicitly detailed in the available data, but the company's consistent operating cash flow and free cash flow suggest a stable financial position. The absence of recent dilutive events or significant capital expenditures may indicate a focus on maintaining financial stability.
- Autek China Inc maintains a strong liquidity position with a current ratio of 5.77.
- The company's ROE of 9.76% and ROA of 7.66% are above industry medians, indicating strong profitability.
- The company's capital structure is conservative, with a debt-to-equity ratio of 0.06.
- Analysts have assigned a generally positive outlook, with a mean price target of 16.28 CNY.
- The company's net cash position is negative after subtracting total debt, which may pose a liquidity risk in the medium term.
- The company's geographic and segment exposure is likely concentrated in the domestic Chinese market.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,72 |
| Revenue | —no estimate | —no estimate | 2,1B CNY |
| Operating income | —no estimate | —no estimate | 812,5M CNY |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Autek China Inc Market data — financials · 2026-05-26
- Autek China Inc Market data — analyst estimates · 2026-05-26
- Autek China Inc Market data — ESG · 2026-05-26